Gut microbiota composition in colorectal cancer patients is genetically regulated.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
06 07 2022
06 07 2022
Historique:
received:
23
03
2022
accepted:
21
06
2022
entrez:
6
7
2022
pubmed:
7
7
2022
medline:
9
7
2022
Statut:
epublish
Résumé
The risk of colorectal cancer (CRC) depends on environmental and genetic factors. Among environmental factors, an imbalance in the gut microbiota can increase CRC risk. Also, microbiota is influenced by host genetics. However, it is not known if germline variants influence CRC development by modulating microbiota composition. We investigated germline variants associated with the abundance of bacterial populations in the normal (non-involved) colorectal mucosa of 93 CRC patients and evaluated their possible role in disease. Using a multivariable linear regression, we assessed the association between germline variants identified by genome wide genotyping and bacteria abundances determined by 16S rRNA gene sequencing. We identified 37 germline variants associated with the abundance of the genera Bacteroides, Ruminococcus, Akkermansia, Faecalibacterium and Gemmiger and with alpha diversity. These variants are correlated with the expression of 58 genes involved in inflammatory responses, cell adhesion, apoptosis and barrier integrity. Genes and bacteria appear to be involved in the same processes. In fact, expression of the pro-inflammatory genes GAL, GSDMD and LY6H was correlated with the abundance of Bacteroides, which has pro-inflammatory properties; abundance of the anti-inflammatory genus Faecalibacterium correlated with expression of KAZN, with barrier-enhancing functions. Both the microbiota composition and local inflammation are regulated, at least partially, by the same germline variants. These variants may regulate the microenvironment in which bacteria grow and predispose to the development of cancer. Identification of these variants is the first step to identifying higher-risk individuals and proposing tailored preventive treatments that increase beneficial bacterial populations.
Identifiants
pubmed: 35794137
doi: 10.1038/s41598-022-15230-6
pii: 10.1038/s41598-022-15230-6
pmc: PMC9259655
doi:
Substances chimiques
RNA, Ribosomal, 16S
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
11424Subventions
Organisme : European Research Council
ID : 825410
Pays : International
Informations de copyright
© 2022. The Author(s).
Références
Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209–249 (2021).
pubmed: 33538338
doi: 10.3322/caac.21660
Arnold, M. et al. Global patterns and trends in colorectal cancer incidence and mortality. Gut 66, 683–691 (2017).
pubmed: 26818619
doi: 10.1136/gutjnl-2015-310912
Keum, N. & Giovannucci, E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat. Rev. Gastroenterol. Hepatol. 16, 713–732 (2019).
pubmed: 31455888
doi: 10.1038/s41575-019-0189-8
Yang, T. et al. Gene–environment interactions and colorectal cancer risk: an umbrella review of systematic reviews and meta-analyses of observational studies. Int. J. Cancer 145, 2315–2329 (2019).
pubmed: 30536881
pmcid: 6767750
doi: 10.1002/ijc.32057
Law, P. J. et al. Association analyses identify 31 new risk loci for colorectal cancer susceptibility. Nat. Commun. 10, 1–15 (2019).
doi: 10.1038/s41467-019-09775-w
Gagnière, J. et al. Gut microbiota imbalance and colorectal cancer. World J. Gastroenterol. 22, 501 (2016).
pubmed: 26811603
pmcid: 4716055
doi: 10.3748/wjg.v22.i2.501
Tremaroli, V. & Bäckhed, F. Functional interactions between the gut microbiota and host metabolism. Nature 489, 242–249 (2012).
pubmed: 22972297
doi: 10.1038/nature11552
Kurilshikov, A. et al. Large-scale association analyses identify host factors influencing human gut microbiome composition. Nat. Genet. 53, 156–165 (2021).
pubmed: 33462485
pmcid: 8515199
doi: 10.1038/s41588-020-00763-1
Grieneisen, L. et al. Gut microbiome heritability is nearly universal but environmentally contingent. Science 373, 181–186 (2021).
pubmed: 34244407
pmcid: 8377764
doi: 10.1126/science.aba5483
Davenport, E. R. Elucidating the role of the host genome in shaping microbiome composition. Gut Microbes 7, 178–184 (2016).
pubmed: 26939746
pmcid: 4856462
doi: 10.1080/19490976.2016.1155022
Hu, S. et al. Whole exome sequencing analyses reveal gene–microbiota interactions in the context of IBD. Gut 70, 285–296 (2021).
pubmed: 32651235
Schmitt, M. & Greten, F. R. The inflammatory pathogenesis of colorectal cancer. Nat. Rev. Immunol. 10, 653–667 (2021).
Wong, S. H. & Yu, J. Gut microbiota in colorectal cancer: mechanisms of action and clinical applications. Nat. Rev. Gastroenterol. Hepatol. 16, 690–704 (2019).
pubmed: 31554963
doi: 10.1038/s41575-019-0209-8
Richardson, T. G. et al. Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: a multivariable Mendelian randomisation analysis. PLoS Med. 17, e1003062 (2020).
pubmed: 32203549
pmcid: 7089422
doi: 10.1371/journal.pmed.1003062
Sinnott-Armstrong, N. et al. Genetics of 35 blood and urine biomarkers in the UK Biobank. Nat. Genet. 53, 185–194 (2021).
pubmed: 33462484
doi: 10.1038/s41588-020-00757-z
Louis, P. & Flint, H. J. Formation of propionate and butyrate by the human colonic microbiota. Environ. Microbiol. 19, 29–41 (2017).
pubmed: 27928878
doi: 10.1111/1462-2920.13589
Bang, S.-J. et al. The influence of in vitro pectin fermentation on the human fecal microbiome. AMB Express 8, 1–9 (2018).
doi: 10.1186/s13568-018-0629-9
Rueter, C. & Bielaszewska, M. Secretion and delivery of intestinal pathogenic Escherichia coli virulence factors via outer membrane vesicles. Front. Cell Infect. Microbiol. 10, 91 (2020).
pubmed: 32211344
pmcid: 7068151
doi: 10.3389/fcimb.2020.00091
Kittana, H. et al. Commensal Escherichia coli strains can promote intestinal inflammation via differential interleukin-6 production. Front. Immunol. 9, 2318 (2018).
pubmed: 30356663
pmcid: 6189283
doi: 10.3389/fimmu.2018.02318
Chen, J. et al. An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis. Genome Med. 8, 1–14 (2016).
doi: 10.1186/s13073-016-0299-7
Azam, M. W. & Khan, A. U. Updates on the pathogenicity status of Pseudomonas aeruginosa. Drug Discov. Today 24, 350–359 (2019).
pubmed: 30036575
doi: 10.1016/j.drudis.2018.07.003
Forbes, J. D. et al. A comparative study of the gut microbiota in immune-mediated inflammatory diseases—does a common dysbiosis exist?. Microbiome 6, 1–15 (2018).
doi: 10.1186/s40168-018-0603-4
Vuik, F. et al. Composition of the mucosa-associated microbiota along the entire gastrointestinal tract of human individuals. United Eur. Gastroenterol. J. 7, 897–907 (2019).
doi: 10.1177/2050640619852255
Huang, D. W., Sherman, B. T. & Lempicki, R. A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37, 1–13 (2009).
doi: 10.1093/nar/gkn923
Ott, S. et al. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 53, 685–693 (2004).
pubmed: 15082587
pmcid: 1774050
doi: 10.1136/gut.2003.025403
Barber, D. F., Faure, M. & Long, E. O. LFA-1 contributes an early signal for NK cell cytotoxicity. J. Immunol. 173, 3653–3659 (2004).
pubmed: 15356110
doi: 10.4049/jimmunol.173.6.3653
Ley, K., Laudanna, C., Cybulsky, M. I. & Nourshargh, S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 7, 678–689 (2007).
pubmed: 17717539
doi: 10.1038/nri2156
Bai, M. et al. CD177 modulates human neutrophil migration through activation-mediated integrin and chemoreceptor regulation. Blood 130, 2092–2100 (2017).
pubmed: 28807980
pmcid: 5680608
doi: 10.1182/blood-2017-03-768507
Mulier, M. et al. Upregulation of TRPM3 in nociceptors innervating inflamed tissue. Elife 9, e61103 (2020).
pubmed: 32880575
pmcid: 7470828
doi: 10.7554/eLife.61103
Boonen, B. et al. Differential effects of lipopolysaccharide on mouse sensory TRP channels. Cell Calcium 73, 72–81 (2018).
pubmed: 29689522
doi: 10.1016/j.ceca.2018.04.004
Wiesner, J. & Vilcinskas, A. Antimicrobial peptides: the ancient arm of the human immune system. Virulence 1, 440–464 (2010).
pubmed: 21178486
doi: 10.4161/viru.1.5.12983
Chen, Y. et al. Pik3ip1 is a negative immune regulator that inhibits antitumor T-cell immunity. Clin. Cancer Res. 25, 6180–6194 (2019).
pubmed: 31350312
doi: 10.1158/1078-0432.CCR-18-4134
Uche, U. U. et al. PIK3IP1/TrIP restricts activation of T cells through inhibition of PI3K/Akt. J. Exp. Med. 215, 3165–3179 (2018).
pubmed: 30429249
pmcid: 6279406
doi: 10.1084/jem.20172018
Wexler, H. M. Bacteroides: the good, the bad, and the nitty-gritty. Clin. Microbiol. Rev. 20, 593–621 (2007).
pubmed: 17934076
pmcid: 2176045
doi: 10.1128/CMR.00008-07
Nakano, V. et al. Adherence and invasion of Bacteroidales isolated from the human intestinal tract. Clin. Microbiol. Infect. 14, 955–963 (2008).
pubmed: 18828854
doi: 10.1111/j.1469-0691.2008.02069.x
Cheng, W. T., Kantilal, H. K. & Davamani, F. The mechanism of Bacteroides fragilis toxin contributes to colon cancer formation. Malays. J. Med. Sci. 27, 9 (2020).
pubmed: 32863742
pmcid: 7444842
Liu, Q.-Q. et al. Enterotoxigenic Bacteroides fragilis induces the stemness in colorectal cancer via upregulating histone demethylase JMJD2B. Gut Microbes 12, 1788900 (2020).
pubmed: 32684087
pmcid: 7524313
doi: 10.1080/19490976.2020.1788900
Benya, R. V., Matkowskyj, K. A., Danilkovich, A. & Hecht, G. Galanin causes Cl− secretion in the human colon: potential significance of inflammation-associated NF-κB activation on galanin-1 receptor expression and function. Ann. N. Y. Acad. Sci. 863, 64–77 (1998).
pubmed: 9928160
doi: 10.1111/j.1749-6632.1998.tb10684.x
Rauch, I., Lundström, L., Hell, M., Sperl, W. & Kofler, B. Galanin message-associated peptide suppresses growth and the budded-to-hyphal-form transition of Candida albicans. Antimicrob. Agents Chemother. 51, 4167–4170 (2007).
pubmed: 17698619
pmcid: 2151459
doi: 10.1128/AAC.00166-07
Shi, J., Gao, W. & Shao, F. Pyroptosis: gasdermin-mediated programmed necrotic cell death. Trends Biochem. Sci. 42, 245–254 (2017).
pubmed: 27932073
doi: 10.1016/j.tibs.2016.10.004
Greenfeder, S. A. et al. Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex∗. J. Biol. Chem. 270, 13757–13765 (1995).
pubmed: 7775431
doi: 10.1074/jbc.270.23.13757
Dmitrieva-Posocco, O. et al. Cell-type-specific responses to interleukin-1 control microbial invasion and tumor-elicited inflammation in colorectal cancer. Immunity 50(166–180), e167 (2019).
Moriwaki, Y. et al. Endogenous neurotoxin-like protein Ly6H inhibits alpha7 nicotinic acetylcholine receptor currents at the plasma membrane. Sci. Rep. 10, 1–11 (2020).
doi: 10.1038/s41598-020-68947-7
Kishibe, M., Griffin, T. M. & Radek, K. A. Keratinocyte nicotinic acetylcholine receptor activation modulates early TLR2-mediated wound healing responses. Int. Immunopharmacol. 29, 63–70 (2015).
pubmed: 26071220
pmcid: 4637223
doi: 10.1016/j.intimp.2015.05.047
Kobatake, E. & Kabuki, T. S-layer protein of Lactobacillus helveticus SBT2171 promotes human β-defensin 2 expression via TLR2–JNK signaling. Front. Microbiol. 10, 2414 (2019).
pubmed: 31681252
pmcid: 6813279
doi: 10.3389/fmicb.2019.02414
Álvarez, Á. H., Velázquez, M. M. & de Oca, E. P. M. Human β-defensin 1 update: Potential clinical applications of the restless warrior. Int. J. Biochem. Cell Biol. 104, 133–137 (2018).
pubmed: 30236992
doi: 10.1016/j.biocel.2018.09.007
Bai, H. et al. The Na+, K+-ATPase β1 subunit regulates epithelial tight junctions via MRCKα. JCI Insight. 6, e134881 (2021).
Zhai, R. et al. Strain-specific anti-inflammatory properties of two Akkermansia muciniphila strains on chronic colitis in mice. Front. Cell Infect. Microbiol. 9, 239 (2019).
pubmed: 31334133
pmcid: 6624636
doi: 10.3389/fcimb.2019.00239
Ottman, N. et al. Pili-like proteins of Akkermansia muciniphila modulate host immune responses and gut barrier function. PLoS ONE 12, e0173004 (2017).
pubmed: 28249045
pmcid: 5332112
doi: 10.1371/journal.pone.0173004
Chelakkot, C. et al. Akkermansia muciniphila-derived extracellular vesicles influence gut permeability through the regulation of tight junctions. Exp. Mol. Med. 50, e450–e450 (2018).
pubmed: 29472701
pmcid: 5903829
doi: 10.1038/emm.2017.282
Borges-Canha, M., Portela-Cidade, J. P., Dinis-Ribeiro, M., Leite-Moreira, A. F. & Pimentel-Nunes, P. Role of colonic microbiota in colorectal carcinogenesis: a systematic review. Rev. Esp. Enferm. Dig. 107, 659–671 (2015).
pubmed: 26541655
doi: 10.17235/reed.2015.3830/2015
Zhang, B., Li, M., Huang, P., Guan, X. Y. & Zhu, Y. H. Overexpression of ubiquitin specific peptidase 14 predicts unfavorable prognosis in esophageal squamous cell carcinoma. Thorac. Cancer 8, 344–349 (2017).
pubmed: 28509417
pmcid: 5494452
doi: 10.1111/1759-7714.12453
Liu, N. et al. Ubiquitin-specific protease 14 regulates LPS-induced inflammation by increasing ERK1/2 phosphorylation and NF-κB activation. Mol. Cell Biochem. 431, 87–96 (2017).
pubmed: 28364380
doi: 10.1007/s11010-017-2978-0
Liu, Y. et al. The role of MUC2 mucin in intestinal homeostasis and the impact of dietary components on MUC2 expression. Int. J. Biol. Macromol. https://doi.org/10.1016/j.ijbiomac.2020.07.191 (2020).
doi: 10.1016/j.ijbiomac.2020.07.191
pubmed: 33736272
pmcid: 7568492
Sokol, H. et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl. Acad. Sci. U. S. A. 105, 16731–16736 (2008).
pubmed: 18936492
pmcid: 2575488
doi: 10.1073/pnas.0804812105
Lopez-Siles, M., Duncan, S. H., Garcia-Gil, L. J. & Martinez-Medina, M. Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics. ISME J. 11, 841–852 (2017).
pubmed: 28045459
pmcid: 5364359
doi: 10.1038/ismej.2016.176
Groot, K. R., Sevilla, L. M., Nishi, K., DiColandrea, T. & Watt, F. M. Kazrin, a novel periplakin-interacting protein associated with desmosomes and the keratinocyte plasma membrane. J. Cell Biol. 166, 653–659 (2004).
pubmed: 15337775
pmcid: 2172441
doi: 10.1083/jcb.200312123
Rodriguez, H. M. et al. Modulation of lysyl oxidase-like 2 enzymatic activity by an allosteric antibody inhibitor. J. Biol. Chem. 285, 20964–20974 (2010).
pubmed: 20439985
pmcid: 2898315
doi: 10.1074/jbc.M109.094136
Mohan, V., Das, A. & Sagi, I. Emerging roles of ECM remodeling processes in cancer. Semin. Cancer Biol. 62, 192–200 (2020).
pubmed: 31518697
doi: 10.1016/j.semcancer.2019.09.004
Gonfloni, S., Caputo, V. & Iannizzotto, V. P63 in health and cancer. Int. J. Dev. Biol. 59, 87–93 (2015).
pubmed: 26374530
doi: 10.1387/ijdb.150045sg
DeCastro, A. J., Cherukuri, P., Balboni, A. & DiRenzo, J. ΔNP63α transcriptionally activates chemokine receptor 4 (CXCR4) expression to regulate breast cancer stem cell activity and chemotaxis. Mol. Cancer Ther. 14, 225–235 (2015).
pubmed: 25376609
doi: 10.1158/1535-7163.MCT-14-0194
Hajishengallis, G., Wang, M., Liang, S., Triantafilou, M. & Triantafilou, K. Pathogen induction of CXCR4/TLR2 cross-talk impairs host defense function. Proc. Natl. Acad. Sci. U. S. A. 105, 13532–13537 (2008).
pubmed: 18765807
pmcid: 2533224
doi: 10.1073/pnas.0803852105
Miao, G. et al. TLR2/CXCR4 coassociation facilitates Chlamydia pneumoniae infection-induced atherosclerosis. Am. J. Physiol. Heart Circ. Physiol. 318, H1420–H1435 (2020).
pubmed: 32330088
doi: 10.1152/ajpheart.00011.2020
Tang, Q. et al. Current sampling methods for gut microbiota: a call for more precise devices. Front. Cell Infect. Microbiol. 10, 151 (2020).
pubmed: 32328469
pmcid: 7161087
doi: 10.3389/fcimb.2020.00151
Noci, S. et al. A subset of genetic susceptibility variants for colorectal cancer also has prognostic value. Pharmacogenom. J. 16, 173–179 (2016).
doi: 10.1038/tpj.2015.35
Amin, M. B. et al. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J. Clin. 67, 93–99 (2017).
pubmed: 28094848
doi: 10.3322/caac.21388
Miyauchi, E. et al. Analysis of colonic mucosa-associated microbiota using endoscopically collected lavage. Sci. Rep. 12, 1–8 (2022).
doi: 10.1038/s41598-022-05936-y
Pinna, N. K., Dutta, A., Monzoorul Haque, M. & Mande, S. S. Can targeting non-contiguous V-regions with paired-end sequencing improve 16S rRNA-based taxonomic resolution of microbiomes?: an in silico evaluation. Front. Genet. 10, 653 (2019).
pubmed: 31354793
pmcid: 6640118
doi: 10.3389/fgene.2019.00653
Lane, D. J. 16S/23S rRNA sequencing. In Nucleic Acid Techniques in Bacterial Systematics (eds Stackebrandt, E. & Goodfellow, M.) 115–175 (John Wiley & Son, 1991).
Turner, S., Pryer, K. M., Miao, V. P. & Palmer, J. D. Investigating deep phylogenetic relationships among cyanobacteria and plastids by small subunit rRNA sequence analysis. J. Eukaryot. Microbiol. 46, 327–338 (1999).
pubmed: 10461381
doi: 10.1111/j.1550-7408.1999.tb04612.x
Weisburg, W. G., Barns, S. M., Pelletier, D. A. & Lane, D. J. 16S ribosomal DNA amplification for phylogenetic study. J. Bacteriol. 173, 697–703 (1991).
pubmed: 1987160
pmcid: 207061
doi: 10.1128/jb.173.2.697-703.1991
Magoč, T. & Salzberg, S. L. FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinformatics 27, 2957–2963 (2011).
pubmed: 21903629
pmcid: 3198573
doi: 10.1093/bioinformatics/btr507
Edgar, R. C., Haas, B. J., Clemente, J. C., Quince, C. & Knight, R. UCHIME improves sensitivity and speed of chimera detection. Bioinformatics 27, 2194–2200 (2011).
pubmed: 21700674
pmcid: 3150044
doi: 10.1093/bioinformatics/btr381
Rognes, T., Flouri, T., Nichols, B., Quince, C. & Mahé, F. VSEARCH: a versatile open source tool for metagenomics. PeerJ 4, e2584 (2016).
pubmed: 27781170
pmcid: 5075697
doi: 10.7717/peerj.2584
Eren, A. M. et al. Oligotyping: differentiating between closely related microbial taxa using 16S rRNA gene data. Methods Ecol. Evol. 4, 1111–1119 (2013).
pmcid: 3864673
doi: 10.1111/2041-210X.12114
Eren, A. M. et al. Minimum entropy decomposition: unsupervised oligotyping for sensitive partitioning of high-throughput marker gene sequences. ISME J. 9, 968–979 (2015).
pubmed: 25325381
doi: 10.1038/ismej.2014.195
Altschul, S. F., Gish, W., Miller, W., Myers, E. W. & Lipman, D. J. Basic local alignment search tool. J. Mol. Biol. 215, 403–410 (1990).
pubmed: 2231712
doi: 10.1016/S0022-2836(05)80360-2
Caporaso, J. G. et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods. 7, 335–336 (2010).
pubmed: 20383131
pmcid: 3156573
doi: 10.1038/nmeth.f.303
Angly, F. E. et al. CopyRighter: a rapid tool for improving the accuracy of microbial community profiles through lineage-specific gene copy number correction. Microbiome 2, 1–13 (2014).
doi: 10.1186/2049-2618-2-11
Colwell, R. Biodiversity: concepts, patterns, and measurement. In The Princeton Guide to Ecology (eds Levin, S. et al.) 257–263 (Princeton University Press, 2009).
doi: 10.1515/9781400833023.257
Aitchison, J. The statistical analysis of compositional data. J. R. Statist. Soc. B 44, 139–160 (1982).
Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559–575 (2007).
pubmed: 17701901
pmcid: 1950838
doi: 10.1086/519795
Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Statist. Soc. B 57, 289–300 (1995).
Xu, C. et al. Estimating genome-wide significance for whole-genome sequencing studies. Genet. Epidemiol. 38, 281–290 (2014).
pubmed: 24676807
pmcid: 4489336
doi: 10.1002/gepi.21797
Lonsdale, J. et al. The genotype-tissue expression (GTEx) project. Nat. Genet. 45, 580–585 (2013).
doi: 10.1038/ng.2653
McLaren, W. et al. The ensembl variant effect predictor. Genome Biol. 17, 1–14 (2016).
doi: 10.1186/s13059-016-0974-4
Li, M., Sun, Q. & Wang, X. Transcriptional landscape of human cancers. Oncotarget 8, 34534 (2017).
pubmed: 28427185
pmcid: 5470989
doi: 10.18632/oncotarget.15837